• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中线粒体质量控制的改变

Alterations in Mitochondrial Quality Control in Alzheimer's Disease.

作者信息

Cai Qian, Tammineni Prasad

机构信息

Department of Cell Biology and Neuroscience, Rutgers, The State University of New Jersey Piscataway, NJ, USA.

出版信息

Front Cell Neurosci. 2016 Feb 9;10:24. doi: 10.3389/fncel.2016.00024. eCollection 2016.

DOI:10.3389/fncel.2016.00024
PMID:26903809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4746252/
Abstract

Mitochondrial dysfunction is one of the earliest and most prominent features in the brains of Alzheimer's disease (AD) patients. Recent studies suggest that mitochondrial dysfunction plays a pivotal role in the pathogenesis of AD. Neurons are metabolically active cells, causing them to be particularly dependent on mitochondrial function for survival and maintenance. As highly dynamic organelles, mitochondria are characterized by a balance of fusion and fission, transport, and mitophagy, all of which are essential for maintaining mitochondrial integrity and function. Mitochondrial dynamics and mitophagy can therefore be identified as key pathways in mitochondrial quality control. Tremendous progress has been made in studying changes in these key aspects of mitochondrial biology in the vulnerable neurons of AD brains and mouse models, and the potential underlying mechanisms of such changes. This review highlights recent findings on alterations in the mitochondrial dynamics and mitophagy in AD and discusses how these abnormalities impact mitochondrial quality control and thus contribute to mitochondrial dysfunction in AD.

摘要

线粒体功能障碍是阿尔茨海默病(AD)患者大脑中最早出现且最为突出的特征之一。最近的研究表明,线粒体功能障碍在AD的发病机制中起关键作用。神经元是代谢活跃的细胞,这使得它们在生存和维持过程中特别依赖线粒体功能。作为高度动态的细胞器,线粒体的特征在于融合与裂变、运输以及线粒体自噬之间的平衡,所有这些对于维持线粒体的完整性和功能都至关重要。因此,线粒体动力学和线粒体自噬可被视为线粒体质量控制的关键途径。在研究AD大脑和小鼠模型中易损神经元中线粒体生物学这些关键方面的变化及其潜在机制方面已经取得了巨大进展。本综述重点介绍了AD中线粒体动力学和线粒体自噬改变的最新发现,并讨论了这些异常如何影响线粒体质量控制,进而导致AD中的线粒体功能障碍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c640/4746252/e803f5e2c22c/fncel-10-00024-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c640/4746252/1b80554f0e76/fncel-10-00024-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c640/4746252/e5f75cfa2e3d/fncel-10-00024-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c640/4746252/1c213b936ab6/fncel-10-00024-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c640/4746252/88e9aca590df/fncel-10-00024-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c640/4746252/ac38b6d91a27/fncel-10-00024-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c640/4746252/e803f5e2c22c/fncel-10-00024-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c640/4746252/1b80554f0e76/fncel-10-00024-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c640/4746252/e5f75cfa2e3d/fncel-10-00024-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c640/4746252/1c213b936ab6/fncel-10-00024-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c640/4746252/88e9aca590df/fncel-10-00024-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c640/4746252/ac38b6d91a27/fncel-10-00024-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c640/4746252/e803f5e2c22c/fncel-10-00024-g0006.jpg

相似文献

1
Alterations in Mitochondrial Quality Control in Alzheimer's Disease.阿尔茨海默病中线粒体质量控制的改变
Front Cell Neurosci. 2016 Feb 9;10:24. doi: 10.3389/fncel.2016.00024. eCollection 2016.
2
Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.阿尔茨海默病发病机制中线粒体动态异常。
J Alzheimers Dis. 2013;33 Suppl 1(0 1):S253-62. doi: 10.3233/JAD-2012-129005.
3
Mechanisms of Mitochondrial Malfunction in Alzheimer's Disease: New Therapeutic Hope.阿尔茨海默病中线粒体功能障碍的机制:新的治疗希望。
Oxid Med Cell Longev. 2022 May 14;2022:4759963. doi: 10.1155/2022/4759963. eCollection 2022.
4
Mitochondrial Dysfunction and Oxidative Stress in Alzheimer's Disease.阿尔茨海默病中的线粒体功能障碍与氧化应激
Front Aging Neurosci. 2021 Feb 18;13:617588. doi: 10.3389/fnagi.2021.617588. eCollection 2021.
5
Defective mitophagy in Alzheimer's disease.阿尔茨海默病中的缺陷线粒体自噬。
Ageing Res Rev. 2020 Dec;64:101191. doi: 10.1016/j.arr.2020.101191. Epub 2020 Oct 3.
6
Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.淀粉样β和磷酸化 tau 诱导的阿尔茨海默病中的自噬和 mitophagy 缺陷。
Cells. 2019 May 22;8(5):488. doi: 10.3390/cells8050488.
7
Mitochondrial dynamics--fusion, fission, movement, and mitophagy--in neurodegenerative diseases.神经退行性疾病中的线粒体动力学——融合、裂变、运动及线粒体自噬
Hum Mol Genet. 2009 Oct 15;18(R2):R169-76. doi: 10.1093/hmg/ddp326.
8
Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.阿尔茨海默病中突触功能障碍的线粒体相关方面
J Alzheimers Dis. 2017;57(4):1087-1103. doi: 10.3233/JAD-160726.
9
Dysfunctional Mitochondria and Mitophagy as Drivers of Alzheimer's Disease Pathogenesis.功能失调的线粒体与线粒体自噬作为阿尔茨海默病发病机制的驱动因素
Front Aging Neurosci. 2019 Nov 20;11:311. doi: 10.3389/fnagi.2019.00311. eCollection 2019.
10
Parkin-mediated mitophagy in mutant hAPP neurons and Alzheimer's disease patient brains.帕金森蛋白介导的突变型人淀粉样前体蛋白神经元及阿尔茨海默病患者大脑中的线粒体自噬
Hum Mol Genet. 2015 May 15;24(10):2938-51. doi: 10.1093/hmg/ddv056. Epub 2015 Feb 12.

引用本文的文献

1
Review of FUNDC1-mediated mitochondrial autophagy in Alzheimer's disease.阿尔茨海默病中FUNDC1介导的线粒体自噬研究综述
Front Aging Neurosci. 2025 May 12;17:1544241. doi: 10.3389/fnagi.2025.1544241. eCollection 2025.
2
Mitochondrial quality control and transfer communication in neurological disorders and neuroinflammation.线粒体质量控制与神经疾病和神经炎症中的传递通讯
Front Immunol. 2025 Apr 28;16:1542369. doi: 10.3389/fimmu.2025.1542369. eCollection 2025.
3
Advances in research on mitochondrial dysfunction in neurodegenerative diseases.

本文引用的文献

1
PARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer's disease.PARK2增强能够补偿散发性阿尔茨海默病中发现的线粒体自噬改变。
Hum Mol Genet. 2016 Feb 15;25(4):792-806. doi: 10.1093/hmg/ddv616. Epub 2015 Dec 31.
2
Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis.发动蛋白相关蛋白1的多面性及其在阿尔茨海默病发病机制中的作用
Biochim Biophys Acta. 2016 Apr;1862(4):814-828. doi: 10.1016/j.bbadis.2015.12.018. Epub 2015 Dec 17.
3
Endolysosomal Deficits Augment Mitochondria Pathology in Spinal Motor Neurons of Asymptomatic fALS Mice.
神经退行性疾病中线粒体功能障碍的研究进展
J Neurol. 2025 Apr 28;272(5):364. doi: 10.1007/s00415-025-13101-4.
4
Mitochondrial quality control disorder in neurodegenerative disorders: Potential and advantages of traditional Chinese medicines.神经退行性疾病中的线粒体质量控制紊乱:中药的潜力与优势
J Pharm Anal. 2025 Apr;15(4):101146. doi: 10.1016/j.jpha.2024.101146. Epub 2024 Nov 14.
5
Discovery of an ApoE4-targeted small-molecule SirT1 enhancer for the treatment of Alzheimer's disease.发现一种靶向载脂蛋白E4的小分子Sirtuin 1增强剂用于治疗阿尔茨海默病。
Sci Rep. 2025 Apr 23;15(1):14028. doi: 10.1038/s41598-025-96131-2.
6
Construction and evaluation of a diagnostic model for Alzheimer's disease based on mitophagy-related genes.基于线粒体自噬相关基因的阿尔茨海默病诊断模型的构建与评估
Sci Rep. 2025 Mar 27;15(1):10632. doi: 10.1038/s41598-025-89980-4.
7
Identifying shared diagnostic genes and mechanisms in vascular dementia and Alzheimer's disease via bioinformatics and machine learning.通过生物信息学和机器学习识别血管性痴呆和阿尔茨海默病中的共享诊断基因及机制。
J Alzheimers Dis Rep. 2024 Nov 24;8(1):1558-1572. doi: 10.1177/25424823241289804. eCollection 2024.
8
Mitochondrial dysfunction in Alzheimer's disease: a key frontier for future targeted therapies.阿尔茨海默病中的线粒体功能障碍:未来靶向治疗的关键前沿领域。
Front Immunol. 2025 Jan 14;15:1484373. doi: 10.3389/fimmu.2024.1484373. eCollection 2024.
9
ATAD1 Regulates Neuronal Development and Synapse Formation Through Tuning Mitochondrial Function.ATAD1通过调节线粒体功能来调控神经元发育和突触形成。
Int J Mol Sci. 2024 Dec 24;26(1):44. doi: 10.3390/ijms26010044.
10
Integrated network pharmacology and brain metabolomics to analyze the mechanism of Dihuang Yinzi intervention in Alzheimer's disease.整合网络药理学与脑代谢组学分析地黄饮子干预阿尔茨海默病的机制
Heliyon. 2024 Feb 28;10(5):e26643. doi: 10.1016/j.heliyon.2024.e26643. eCollection 2024 Mar 15.
内溶酶体缺陷加剧无症状性家族性肌萎缩侧索硬化症小鼠脊髓运动神经元中的线粒体病理变化。
Neuron. 2015 Jul 15;87(2):355-70. doi: 10.1016/j.neuron.2015.06.026.
4
The Organization of Mitochondrial Quality Control and Life Cycle in the Nervous System In Vivo in the Absence of PINK1.在缺乏PINK1的情况下,体内神经系统中线粒体质量控制与生命周期的组织
J Neurosci. 2015 Jun 24;35(25):9391-401. doi: 10.1523/JNEUROSCI.1198-15.2015.
5
Axonal autophagosomes recruit dynein for retrograde transport through fusion with late endosomes.轴突自噬体通过与晚期内体融合招募动力蛋白进行逆行运输。
J Cell Biol. 2015 May 11;209(3):377-86. doi: 10.1083/jcb.201412046. Epub 2015 May 4.
6
Mitochondrial division and fusion in metabolism.线粒体分裂与融合在代谢中的作用
Curr Opin Cell Biol. 2015 Apr;33:111-8. doi: 10.1016/j.ceb.2015.02.001. Epub 2015 Feb 19.
7
NH2-truncated human tau induces deregulated mitophagy in neurons by aberrant recruitment of Parkin and UCHL-1: implications in Alzheimer's disease.氨基端截短的人tau蛋白通过异常募集帕金蛋白和泛素羧基末端水解酶L1诱导神经元中自噬调节异常:对阿尔茨海默病的影响
Hum Mol Genet. 2015 Jun 1;24(11):3058-81. doi: 10.1093/hmg/ddv059. Epub 2015 Feb 15.
8
Parkin-mediated mitophagy in mutant hAPP neurons and Alzheimer's disease patient brains.帕金森蛋白介导的突变型人淀粉样前体蛋白神经元及阿尔茨海默病患者大脑中的线粒体自噬
Hum Mol Genet. 2015 May 15;24(10):2938-51. doi: 10.1093/hmg/ddv056. Epub 2015 Feb 12.
9
Axonal Charcot-Marie-Tooth disease patient-derived motor neurons demonstrate disease-specific phenotypes including abnormal electrophysiological properties.来自轴索性夏科-马里-图思病患者的运动神经元表现出疾病特异性表型,包括异常的电生理特性。
Exp Neurol. 2015 Jan;263:190-9. doi: 10.1016/j.expneurol.2014.10.005. Epub 2014 Oct 30.
10
Mitochondrial dynamics and inheritance during cell division, development and disease.细胞分裂、发育及疾病过程中的线粒体动力学与遗传
Nat Rev Mol Cell Biol. 2014 Oct;15(10):634-46. doi: 10.1038/nrm3877. Epub 2014 Sep 17.